D3 Bio Investigative Site

Harbin, Heilongjiang 150088

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors With MAPK Pathway Mutations, HER-2 Positive Advanced Solid Tumors

Studies at this site

• A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations — Recruiting now
• A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors — Recruiting now